On December 17, Vice President Huang Yisheng, Deputy Director of Maoming People's Hospital in Guangdong Province and Discipline Leader of Oncology, along with Director Huang Wendong of the hospital's Scientific Research Department, visited Shenzhen Cell Valley for exchange and discussion. Our Chairman, Professor Shi Yuanyuan, Commercial Director Wei Zheng, and Director Yang Jianglong of the Marketing Department extended a warm welcome and participated in the symposium.

With a detailed introduction by Commercial Director Wei Zheng, the visiting leaders toured Shenzhen Cell Valley's digital smart exhibition hall, gaining deeper insight into the company's strategic deployment, the uniqueness of its core technologies, and future development trends. Subsequently, they visited the R&D, production, and quality management laboratories, obtaining a more intuitive understanding of the operational processes and quality management systems.

During the symposium, Professor Shi Yuanyuan noted that Shenzhen Cell Valley has established substantial and comprehensive collaborations with multiple hospitals, accumulating considerable successful experience in co-building cell preparation centers and jointly applying for clinical research projects. Recently, many regions have successively released policies to promote the cell therapy industry. As a multi-billion-dollar health industry, cell therapy has entered an accelerated development phase. Shenzhen Cell Valley has made early strategic moves in the cell and gene therapy industry and remains committed to the original mission of "saving lives and healing patients," adhering to the core principle that "product quality is the lifeblood of the enterprise and the cornerstone of sustainable development." The company closely follows policy trends, fully leverages its advanced technologies and talent reserve, actively contributes to the development of the cell and gene therapy industry chain, and strives to make positive contributions to the highquality development of China's cell and gene therapy industry.

Vice President Huang Yisheng expressed high recognition for Shenzhen Cell Valley's core technologies and clinical application cases. He introduced that Maoming People's Hospital is the first comprehensive grade-A tertiary hospital in the Maoming region and a key construction hospital under Guangdong Province's High-Level Hospital Development Program. Its Oncology and Infectious Diseases departments are key clinical specialties supported by the provincial government. The hospital consistently adheres to its motto of "Virtue, Precision Medicine, Humanity, and Universal Love" and embraces an inclusive and diverse cultural ethos, upholding the patient-centered philosophy to serve the health needs of the broader community. The purpose of this visit was to gain insight into the current state of cell and gene therapy development through Shenzhen Cell Valley, thereby exploring potential collaboration in the cell therapy field at Maoming People's Hospital.

This exchange enhanced mutual understanding between both parties. Both sides expressed the hope to engage in broader cooperation in the future, deepen joint efforts in building cell preparation centers, and collaboratively apply for clinical research projects, working together toward their shared vision of advancing human health.